MS
Mahesh Suresh Javale
About Mahesh Suresh Javale
Data last updated:
Mahesh Suresh Javale is a Nominee Director at Apicore Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Apicore Pharmaceuticals Private Limited reported revenue of ₹195 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Apicore Pharmaceuticals Private Limited U24119GJ2006FTC048777 | Nominee Director | 12 Nov 2023 | 2006 | ₹195 Cr (FY 2024) | Active |
Board colleagues of Mahesh Suresh Javale
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anjali Hemant Prasad | Apicore Pharmaceuticals Private Limited | Company Secretary | |
| Jayaraman Kannappan | 07016114 | Apicore Pharmaceuticals Private Limited | Whole-Time Director |
| Murali Krishna Madala | 00928526 | Apicore Pharmaceuticals Private Limited | Managing Director |
| Parthiv Patel | 07876985 | Apicore Pharmaceuticals Private Limited | Director |
| Ravishanker Kovi | 00278107 | Apicore Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mahesh Suresh Javale
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mahesh Suresh Javale
Mahesh Suresh Javale currently holds 1 directorship: Apicore Pharmaceuticals Private Limited (Nominee Director, since 12 Nov 2023, revenue ₹195 Cr (FY 2024)).
Mahesh Suresh Javale was first appointed on 12 Nov 2023 as Nominee Director at Apicore Pharmaceuticals Private Limited.
The current boards of Mahesh Suresh Javale's companies include Anjali Hemant Prasad (Apicore Pharmaceuticals Private Limited), Jayaraman Kannappan (Apicore Pharmaceuticals Private Limited), Murali Krishna Madala (Apicore Pharmaceuticals Private Limited), Parthiv Patel (Apicore Pharmaceuticals Private Limited), Ravishanker Kovi (Apicore Pharmaceuticals Private Limited).